323 related articles for article (PubMed ID: 26501697)
1. Alvimopan Provides Additional Improvement in Outcomes and Cost Savings in Enhanced Recovery Colorectal Surgery.
Adam MA; Lee LM; Kim J; Shenoi M; Mallipeddi M; Aziz H; Stinnett S; Sun Z; Mantyh CR; Thacker JK
Ann Surg; 2016 Jul; 264(1):141-6. PubMed ID: 26501697
[TBL] [Abstract][Full Text] [Related]
2. Is there value in alvimopan in minimally invasive colorectal surgery?
Keller DS; Flores-Gonzalez JR; Ibarra S; Mahmood A; Haas EM
Am J Surg; 2016 Nov; 212(5):851-856. PubMed ID: 27262754
[TBL] [Abstract][Full Text] [Related]
3. Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system.
Absher RK; Gerkin TM; Banares LW
Ann Pharmacother; 2010 Nov; 44(11):1701-8. PubMed ID: 20858770
[TBL] [Abstract][Full Text] [Related]
4. Alvimopan Significantly Reduces Length of Stay and Costs Following Colorectal Resection and Ostomy Reversal Even Within an Enhanced Recovery Protocol.
Hyde LZ; Kiely JM; Al-Mazrou A; Zhang H; Lee-Kong S; Kiran RP
Dis Colon Rectum; 2019 Jun; 62(6):755-761. PubMed ID: 30807457
[TBL] [Abstract][Full Text] [Related]
5. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy.
Huang JT; Cole AP; Mossanen M; Preston MA; Wang Y; Kibel AS; Chung BI; Huang WJ; Chang SL
Urology; 2020 Jun; 140():115-121. PubMed ID: 32268172
[TBL] [Abstract][Full Text] [Related]
6. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
Kauf TL; Svatek RS; Amiel G; Beard TL; Chang SS; Fergany A; Karnes RJ; Koch M; O'Hara J; Lee CT; Sexton WJ; Slaton JW; Steinberg GD; Wilson SS; Techner L; Martin C; Moreno J; Kamat AM
J Urol; 2014 Jun; 191(6):1721-7. PubMed ID: 24342144
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion.
Vora A; Marchalik D; Nissim H; Kowalczyk K; Bandi G; McGeagh K; Lynch J; Venkatesan K; Ghasemian R; Hwang J; Hwang MV
Can J Urol; 2014 Apr; 21(2):7222-7. PubMed ID: 24775576
[TBL] [Abstract][Full Text] [Related]
8. Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
Earnshaw SR; Kauf TL; McDade C; Potashman MH; Pauyo C; Reese ES; Senagore A
J Am Coll Surg; 2015 Nov; 221(5):941-50. PubMed ID: 26353904
[TBL] [Abstract][Full Text] [Related]
9. Fast-track pathway for minimally invasive colorectal surgery with and without alvimopan (Entereg)™: which is more cost-effective?
Kelley SR; Wolff BG; Lovely JK; Larson DW
Am Surg; 2013 Jun; 79(6):630-3. PubMed ID: 23711275
[TBL] [Abstract][Full Text] [Related]
10. Alvimopan is associated with favorable outcomes in open and minimally invasive colorectal surgery: a regional database analysis.
Kaarto P; Westfall KM; Brockhaus K; Paulus AL; Albright J; Ramm C; Cleary RK
Surg Endosc; 2023 Aug; 37(8):6097-6106. PubMed ID: 37130983
[TBL] [Abstract][Full Text] [Related]
11. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis.
Hilton WM; Lotan Y; Parekh DJ; Basler JW; Svatek RS
BJU Int; 2013 Jun; 111(7):1054-60. PubMed ID: 23171223
[TBL] [Abstract][Full Text] [Related]
12. A statewide, community-based assessment of alvimopan's effect on surgical outcomes.
Harbaugh CM; Al-Holou SN; Bander TS; Drews JD; Shah MM; Terjimanian MN; Cai S; Campbell DA; Englesbe MJ
Ann Surg; 2013 Mar; 257(3):427-32. PubMed ID: 23388351
[TBL] [Abstract][Full Text] [Related]
13. Alvimopan Use, Outcomes, and Costs: A Report from the Surgical Care and Outcomes Assessment Program Comparative Effectiveness Research Translation Network Collaborative.
; Ehlers AP; Simianu VV; Bastawrous AL; Billingham RP; Davidson GH; Fichera A; Florence MG; Menon R; Thirlby RC; Flum DR; Farjah F
J Am Coll Surg; 2016 May; 222(5):870-7. PubMed ID: 27113517
[TBL] [Abstract][Full Text] [Related]
14. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
Lee CT; Chang SS; Kamat AM; Amiel G; Beard TL; Fergany A; Karnes RJ; Kurz A; Menon V; Sexton WJ; Slaton JW; Svatek RS; Wilson SS; Techner L; Bihrle R; Steinberg GD; Koch M
Eur Urol; 2014 Aug; 66(2):265-72. PubMed ID: 24630419
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of alvimopan for prevention and management of postoperative ileus.
Touchette DR; Yang Y; Tiryaki F; Galanter WL
Pharmacotherapy; 2012 Feb; 32(2):120-8. PubMed ID: 22392420
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of alvimopan following bowel resection: a comparison of two dosing strategies.
Winegar B; Cox M; Truelove D; Brock G; Scherrer N; Pass LA
Ann Pharmacother; 2013 Nov; 47(11):1406-13. PubMed ID: 24285757
[TBL] [Abstract][Full Text] [Related]
17. Alvimopan in the setting of colorectal resection with an ostomy: To use or not to use?
Wen Y; Jabir MA; Keating M; Althans AR; Brady JT; Champagne BJ; Delaney CP; Steele SR
Surg Endosc; 2017 Sep; 31(9):3483-3488. PubMed ID: 27928668
[TBL] [Abstract][Full Text] [Related]
18. Alvimopan addition to a standard perioperative recovery pathway.
Itawi EA; Savoie LM; Hanna AJ; Apostolides GY
JSLS; 2011; 15(4):492-8. PubMed ID: 22643504
[TBL] [Abstract][Full Text] [Related]
19. Real world efficacy of alvimopan on elective bowel resection patients: an analysis of statistical versus clinical significance.
Gaines SL; Giroux K; Thomas S; Gregory JS
Am J Surg; 2012 Mar; 203(3):308-11; discussion 311-2. PubMed ID: 22178482
[TBL] [Abstract][Full Text] [Related]
20. Alvimopan is associated with decreased length of stay for both open and laparoscopic segmental colectomy.
Henning RE; Hu KY; Rein LE; Szabo A; Peterson CY; Ludwig KA; Ridolfi TJ
Surgery; 2019 Oct; 166(4):483-488. PubMed ID: 31345565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
